Meropenem Steriscience (Meropenem)

Meropenem is a broad‑spectrum carbapenem used for serious infections caused by Gram‑negative and Gram‑positive bacteria. It is indicated for:

• Complicated intra‑abdominal infections: eradicates mixed aerobic and anaerobic pathogens.
• Hospital‑acquired pneumonia, including ventilator‑associated pneumonia: provides rapid bacterial clearance.
• Complicated urinary tract infections: treats resistant Enterobacteriaceae.
• Bacterial meningitis: penetrates the cerebrospinal fluid to eliminate causative organisms.
• Sepsis and febrile neutropenia: offers empiric coverage against multidrug‑resistant organisms.

• Meropenem inhibits bacterial cell wall synthesis by binding with high affinity to penicillin‑binding proteins (PBPs). This binding blocks the transpeptidation step of peptidoglycan cross‑linking, leading to a weakened cell wall and ultimately bacterial lysis and death. Its broad spectrum includes many Gram‑negative, Gram‑positive, and anaerobic organisms, and it is resistant to most β‑lactamases.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: may be watery and self‑limiting.
• Rash: erythematous skin eruptions.
• Headache: transient and usually resolves.
• Phlebitis at infusion site: redness and tenderness.
• Elevated liver enzymes: transient transaminase rise.

Serious or Rare Side Effects

• Seizures: especially in patients with renal dysfunction.
• Anaphylaxis: acute hypersensitivity reaction.
• Clostridioides difficile‑associated diarrhea: severe colitis.
• Renal impairment: acute kidney injury.
• Severe neutropenia: marked reduction in neutrophil count.
• Thrombocytopenia: low platelet levels leading to bleeding risk.

Before initiating therapy, consider the following precautions:

• Renal function: adjust dose in patients with impaired clearance.
• Allergy: avoid if hypersensitivity to carbapenems or β‑lactams exists.
• Pregnancy: use only when benefits outweigh potential risks.
• Concomitant valproic acid: monitor for reduced anticonvulsant levels.
• Drug‑resistant organisms: obtain susceptibility data before use.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with several agents that alter its efficacy or safety.

Major Interactions (Avoid)

• Valproic acid: reduces plasma concentrations, risking seizure breakthrough.
• Probenecid: may increase meropenem levels, heightening toxicity.

Moderate Interactions (Monitor Closely)

• Loop diuretics: monitor electrolytes for additive nephrotoxicity.
• Aminoglycosides: watch for combined renal impairment.
• Anticoagulants (warfarin): check INR for possible potentiation.
• Other antibiotics: assess for antagonistic effects when combined with bacteriostatic agents.